Login Register Cart 0
Generic placeholder image

Recent Patents on Nanotechnology

Editor-in-Chief

ISSN (Print): 1872-2105
ISSN (Online): 2212-4020

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Self-microemulsifying Drug Delivery System for Problematic Molecules: An Update

Author(s): Dilpreet Singh, Ashok K. Tiwary and Neena Bedi*

Volume 13, Issue 2, 2019

Page: [92 - 113] Pages: 22

DOI: 10.2174/1872210513666190619102521

Price: $65

Abstract

Background: The poor bioavailability of a problematic molecule is predominantly due to its high lipophilicity, low solubility in gastric fluids and/or high fist pass metabolism. Self microemulsifying drug delivery system (SMEDDS), a lipidic type IV nano-formulation has been of interest in the field of pharmaceutical research due to its potential for tailoring the physicochemical properties of pharmaceutical molecules.

Methods: This review provides insights on various recent innovations and reports from the past seven years (2012-2019) of self-emulsifying formulations for the delivery of various types of poorly soluble drugs, phytoconstituents and high molecular peptides and gives exhaustive details of the outcome of the endeavors in this field.

Results: Various types of innovative formulations have been molded from SMEDDS like selfemulsifying powders, granules, tablets, pellets, eutectic and cationic formulations. Till date, many research reports and patents have been filed on self-emulsifying dosage forms and many formulations have gained US-FDA approvals which are summarized in the review article.

Conclusion: This review content highlighted the increasing scope of SMEDDS in augmenting the physiochemical properties of an API, the variegated formulation types and the attributes of API that can be improved by SMEDD based formulations.

Keywords: Solubility enhancement, bioavailability enhancement, SMEDDS, phytoconstituents, peptides, supersaturation, patents.

« Previous Next »
Graphical Abstract

[1]
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001; 46(1-3): 3-26.
[http://dx.doi.org/10.1016/S0169-409X(00)00129-0] [PMID: 11259830]
[2]
Faller B, Ertl P. Computational approaches to determine drug solubility. Adv Drug Deliv Rev 2007; 59(7): 533-45.
[http://dx.doi.org/10.1016/j.addr.2007.05.005] [PMID: 17588703]
[3]
Dressman JB, Vertzoni M, Goumas K, Reppas C. Estimating drug solubility in the gastrointestinal tract. Adv Drug Deliv Rev 2007; 59(7): 591-602.
[http://dx.doi.org/10.1016/j.addr.2007.05.009] [PMID: 17599644]
[4]
Elder D, Holm R. Aqueous solubility: simple predictive methods (in silico, in vitro and bio-relevant approaches). Int J Pharm 2013; 453(1): 3-11.
[http://dx.doi.org/10.1016/j.ijpharm.2012.10.041] [PMID: 23124107]
[5]
Stegemann S, Leveiller F, Franchi D, de Jong H, Lindén H. When poor solubility becomes an issue: from early stage to proof of concept. Eur J Pharm Sci 2007; 31(5): 249-61.
[http://dx.doi.org/10.1016/j.ejps.2007.05.110] [PMID: 17616376]
[6]
Hu N, Frueh J, Zheng C, Zhang B, He Q. Photo-cross-linked natural polyelectrolyte multilayer capsules for drug delivery. Colloids Surfac A Physicochem Engin Aspects 2015; 482: 315-23.
[7]
Gai M, Frueh J, Kudryavtseva VL, Yashchenok AM, Sukhorukov GB. Polylactic acid sealed polyelectrolyte multilayer microchambers for entrapment of salts and small hydrophilic molecules precipitates. ACS Appl Mater Interfaces 2017; 9(19): 16536-45.
[http://dx.doi.org/10.1021/acsami.7b03451] [PMID: 28452456]
[8]
Löbenberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm 2000; 50(1): 3-12.
[http://dx.doi.org/10.1016/S0939-6411(00)00091-6] [PMID: 10840189]
[9]
Singhal D, Curatolo W. Drug polymorphism and dosage form design: a practical perspective. Adv Drug Deliv Rev 2004; 56(3): 335-47.
[http://dx.doi.org/10.1016/j.addr.2003.10.008] [PMID: 14962585]
[10]
Parmod K, Peeyush K, Rajeev K, Nitish K. An overview of lipid based formulations for oral drug delivery. Drug Discov Today 2010; 2: 390-5.
[11]
Singh D, Bedi N, Tiwary AK. Enhancing solubility of poorly aqueous soluble techniques: critical appraisal of techniques. J Pharm Investig 2017; 48(5): 509-26.
[http://dx.doi.org/10.1007/s40005-017-0357-1]
[12]
Porter CJ, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev 2008; 60(6): 673-91.
[http://dx.doi.org/10.1016/j.addr.2007.10.014] [PMID: 18155801]
[13]
Ranade VV, Cannon JB. Oral Drug Delivery, In Drug Delivery Systems. 3rd Edition CRC Press, Florida
[14]
Pouton CW. 2000; Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems. Eur J Pharm Sci 2000; (suppl.)S93-8.
[http://dx.doi.org/10.1016/S0928-0987(00)00167-6]
[15]
Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev 2007; 59(7): 667-76.
[http://dx.doi.org/10.1016/j.addr.2007.05.006] [PMID: 17618704]
[16]
Mu H, Holm R, Müllertz A. Lipid-based formulations for oral administration of poorly water-soluble drugs. Int J Pharm 2013; 453(1): 215-24.
[http://dx.doi.org/10.1016/j.ijpharm.2013.03.054] [PMID: 23578826]
[17]
Mohsin K, Long MA, Pouton CW. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. J Pharm Sci 2009; 98(10): 3582-95.
[http://dx.doi.org/10.1002/jps.21659] [PMID: 19130605]
[18]
Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007; 6(3): 231-48.
[http://dx.doi.org/10.1038/nrd2197] [PMID: 17330072]
[19]
O’Driscoll CM. Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 2002; 15(5): 405-15.
[http://dx.doi.org/10.1016/S0928-0987(02)00051-9] [PMID: 12036717]
[20]
Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev 2008; 60(6): 734-46.
[http://dx.doi.org/10.1016/j.addr.2007.09.006] [PMID: 18045728]
[21]
Mercke Odeberg J, Lignell A, Pettersson A, Höglund P. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. Eur J Pharm Sci 2003; 19(4): 299-304.
[http://dx.doi.org/10.1016/S0928-0987(03)00135-0] [PMID: 12885395]
[22]
Mohsin K, Long MA, Pouton CW. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: Precipitation of drug after dispersion of formulations in aqueous solution. J Pharm Sci 2009; 98(10): 3582-95.
[http://dx.doi.org/10.1002/jps.21659] [PMID: 19130605]
[23]
Prabhu S, Ortega M, Ma C. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam. Int J Pharm 2005; 301(1-2): 209-16.
[http://dx.doi.org/10.1016/j.ijpharm.2005.05.032] [PMID: 16046087]
[24]
Dahan A, Hoffman A. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. Eur J Pharm Biopharm 2007; 67(1): 96-105.
[http://dx.doi.org/10.1016/j.ejpb.2007.01.017] [PMID: 17329087]
[25]
Date AA, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: Formulation insights, applications and advances. Nanomedicine (Lond) 2010; 5(10): 1595-616.
[http://dx.doi.org/10.2217/nnm.10.126] [PMID: 21143036]
[26]
Dokania S, Joshi AK. Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead. Drug Deliv 2015; 22(6): 675-90.
[http://dx.doi.org/10.3109/10717544.2014.896058] [PMID: 24670091]
[27]
Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J. Potentials and challenges in self-nanoemulsifying drug delivery systems. Expert Opin Drug Deliv 2012; 9(10): 1305-17.
[http://dx.doi.org/10.1517/17425247.2012.719870] [PMID: 22954323]
[28]
Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004; 58(3): 173-82.
[http://dx.doi.org/10.1016/j.biopha.2004.02.001] [PMID: 15082340]
[29]
Patel D, Sawant KK. Self micro-emulsifying drug delivery system: formulation development and biopharmaceutical evaluation of lipophilic drugs. Curr Drug Deliv 2009; 6(4): 419-24.
[http://dx.doi.org/10.2174/156720109789000519] [PMID: 19534704]
[30]
Jethara SI, Patel AD, Patel MR. Recent patents survey on self emulsifying drug delivery system. Recent Pat Drug Deliv Formul 2014; 8(3): 233-43.
[http://dx.doi.org/10.2174/1872211308666140821120203] [PMID: 25146965]
[31]
Gurram AK, Deshpande PB, Kar SS, Nayak UY, Udupa N, Reddy MS. Role of components in the formation of self-microemulsifying drug delivery systems. Indian J Pharm Sci 2015; 77(3): 249-57.
[http://dx.doi.org/10.4103/0250-474X.159596] [PMID: 26180269]
[32]
Constantinides PP, Yiv SH. Particle size determination of phase-inverted water-in-oil microemulsions under different dilution and storage conditions. Int J Pharm 1995; 115: 225-34.
[http://dx.doi.org/10.1016/0378-5173(94)00272-7]
[33]
Chen ML. Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective. Adv Drug Deliv Rev 2008; 60(6): 768-77.
[http://dx.doi.org/10.1016/j.addr.2007.09.010] [PMID: 18077051]
[34]
Subramanian R, Wasan KM. Effect of lipid excipients on in vitro pancreatic lipase activity. Drug Dev Ind Pharm 2003; 29(8): 885-90.
[http://dx.doi.org/10.1081/DDC-120024184] [PMID: 14570309]
[35]
Rege BD, Kao JP, Polli JE. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci 2002; 16(4-5): 237-46.
[http://dx.doi.org/10.1016/S0928-0987(02)00055-6] [PMID: 12208453]
[36]
Ren S, Park MJ, Kim A, Lee BJ. In vitro metabolic stability of moisture-sensitive rabeprazole in human liver microsomes and its modulation by pharmaceutical excipients. Arch Pharm Res 2008; 31(3): 406-13.
[http://dx.doi.org/10.1007/s12272-001-1171-z] [PMID: 18409057]
[37]
Mountfield RJ, Senepin S, Schleimer M, Walter I, Bittner B. Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450. Int J Pharm 2000; 211(1-2): 89-92.
[http://dx.doi.org/10.1016/S0378-5173(00)00586-X] [PMID: 11137342]
[38]
Thomson ABR, Keelan M, Garg ML, Clandinin MT. Intestinal aspects of lipid absorption: in review. Can J Physiol Pharmacol 1989; 67(3): 179-91.
[http://dx.doi.org/10.1139/y89-031] [PMID: 2663123]
[39]
Singh D, Tiwary AK, Bedi N. Canagliflozin loaded SMEDDS: Formulation optimization for improved solubility, permeability and pharmacokinetic performance. J Pharm Investig 49(1): 66-85.
[http://dx.doi.org/10.1007/s40005-018-0385-5]
[40]
Mendes C, Buttchevitz A, Kruger JH, et al. Self-Nanoemulsified Drug Delivery System of Hydrochlorothiazide for Increasing Dissolution Rate and Diuretic Activity. AAPS PharmSciTech 2017; 18(7): 2494-504.
[http://dx.doi.org/10.1208/s12249-017-0735-z] [PMID: 28213844]
[41]
Senapati PC, Sahoo SK, Sahu AN. Mixed surfactant based (SNEDDS) self-nanoemulsifying drug delivery system presenting efavirenz for enhancement of oral bioavailability. Biomed Pharmacother 2016; 80: 42-51.
[http://dx.doi.org/10.1016/j.biopha.2016.02.039] [PMID: 27133038]
[42]
Kaseem AA, Mohsen AM, Ahmed RS, Essan TM. Self-nanoemulsifying drug delivery system (SMEDDS) with enhanced solubilization of nystatin for treatment of oral candidiasis: Design, optimization, in vitro and in vivo evaluation. J Mol Lipids 2016; 218: 219-32.
[43]
Janković J, Djekic L, Dobričić V, Primorac M. Evaluation of critical formulation parameters in design and differentiation of self-microemulsifying drug delivery systems (SMEDDSs) for oral delivery of aciclovir. Int J Pharm 2016; 497(1-2): 301-11.
[http://dx.doi.org/10.1016/j.ijpharm.2015.11.011] [PMID: 26611669]
[44]
Hong EP, Kim JY, Kim SH, et al. Formulation and Evaluation of a Self-microemulsifying Drug Delivery System Containing Bortezomib. Chem Pharm Bull (Tokyo) 2016; 64(8): 1108-17.
[http://dx.doi.org/10.1248/cpb.c16-00035] [PMID: 27477648]
[45]
Puri R, Mahajan M, Sahajpal NS, Singh H, Singh H, Jain SK. Self-nanoemulsifying drug delivery system of docosahexanoic acid: development, in vitro, in vivo characterization. Drug Dev Ind Pharm 2016; 42(7): 1032-41.
[http://dx.doi.org/10.3109/03639045.2015.1107089] [PMID: 26559059]
[46]
Fahmy UA, Ahmed OA, Hosny KM. Development and evaluation of avanafil self-nanoemulsifying drug delivery system with rapid onset of action and enhanced bioavailability. AAPS PharmSciTech 2015; 16(1): 53-8.
[http://dx.doi.org/10.1208/s12249-014-0199-3] [PMID: 25168449]
[47]
Michaelsen MH, Wasan KM, Sivak O, Mullertz A, Rades T. The effect of digestion and drug load on halofantrine absorption from self-nanoemulsifying drug delivery system (SMEDDS). AAPS PharmSciTech 2015; 18(1): 180-6.
[http://dx.doi.org/10.1208/s12248-015-9832-7]
[48]
Han SD, Jung SW, Jang SW, Son M, Kim BM, Kang MJ. Reduced food effect on intestinal absorption of dronedarone by self-microemulsifying drug delivery system (SMEDDS). Biol Pharm Bull 2015; 38(7): 1026-32.
[http://dx.doi.org/10.1248/bpb.b15-00110] [PMID: 26133712]
[49]
Subramanian N, Sharavanan SP, Chandrasekar P, Balakumar A, Moulik SP. Lacidipine self-nanoemulsifying drug delivery system for the enhancement of oral bioavailability. Arch Pharm Res 2016; 39(4): 481-91.
[http://dx.doi.org/10.1007/s12272-015-0657-9] [PMID: 26362165]
[50]
Chaurasiya A, Singh AK, Jain GK, et al. Dual approach utilizing self microemulsifying technique and novel P-gp inhibitor for effective delivery of taxanes. J Microencapsul 2012; 29(6): 583-95.
[http://dx.doi.org/10.3109/02652048.2012.668959] [PMID: 22439872]
[51]
Li S, Madan P, Lin S. Application of Capmul MCM and caprylic acid for the development of danazol-loaded SEDDS. Pharm Dev Technol 2015; 20(7): 886-96.
[http://dx.doi.org/10.3109/10837450.2014.943408] [PMID: 25059382]
[52]
Baek MK, Lee JH, Cho YH, Kim HH, Lee GW. Self-microemulsifying drug-delivery system for improved oral bioavailability of pranlukast hemihydrate: Preparation and evaluation. Int J Nanomedicine 2013; 8: 167-76.
[PMID: 23326192]
[53]
Rahman A, Iqbal Z, Hussain A. Formulation optimization and in-vitro characterization of sertraline loaded self-nanoemulsifying drug delivery system (SMEDDS) for oral administration. J Pharm Investig 2012; 42: 191-02.
[http://dx.doi.org/10.1007/s40005-012-0029-0]
[54]
Tang B, Cheng G, Gu JC, Xu CH. Development of solid self-emulsifying drug delivery systems: Preparation techniques and dosage forms. Drug Discov Today 2008; 13(13-14): 606-12.
[http://dx.doi.org/10.1016/j.drudis.2008.04.006] [PMID: 18598917]
[55]
Tarate B, Chavan R, Bansal AK. Oral solid self-emulsifying formulations: a patent review. Recent Pat Drug Deliv Formul 2014; 8(2): 126-43.
[http://dx.doi.org/10.2174/1872211308666140313145836] [PMID: 24628371]
[56]
Midha K, Nagpal M, Singh G, Aggarwal G. Prospectives of solid self-microemulsifying systems in novel drug delivery. Curr Drug Deliv 2017; 14(8): 1078-96.
[http://dx.doi.org/10.2174/1567201813666160824123504] [PMID: 27557673]
[57]
Tan A, Rao S, Prestidge CA. Transforming lipid-based oral drug delivery systems into solid dosage forms: An overview of solid carriers, physicochemical properties, and biopharmaceutical performance. Pharm Res 2013; 30(12): 2993-3017.
[http://dx.doi.org/10.1007/s11095-013-1107-3] [PMID: 23775443]
[58]
Kalepu S, Manthina M, Padavala V. Oral lipid based drug delivery systems: an overview. Acta Pharm Sin B 2013; 3(6): 361-72.
[http://dx.doi.org/10.1016/j.apsb.2013.10.001]
[59]
Singh D, Tiwary AK, Bedi N. Role of porous carriers in the biopharmaceutical performance of solid SMEDDS of canagliflozin. Recent Pat Drug Deliv Formul 2018; 12(3): 179-98.
[http://dx.doi.org/10.2174/1872211312666181008111354] [PMID: 30295193]
[60]
Saleem HF, Kharshoum RM, Halawa AK, Naguib DM. Preparation and optimization of tablets containing a Self nano-emulsifying drug delivery system loaded with rosuvastatin. J Liposome Res 2017; 13: 1-12.
[PMID: 28287014]
[61]
Ahsan MN, Verma PR. Enhancement of in vitro dissolution and pharmacodynamics potential of olanzapine using solid SMEDDS. J Pharm Investig 2017; 48(3): 269-78.
[http://dx.doi.org/10.1007/s40005-017-0308-x]
[62]
Madhav KV, Kishan V. Cationic solid self micro emulsifying drug delivery system (SSMED) of losartan: Formulation development, characterization and in vivo evaluation. J Drug Deliv Sci Technol 2016; 63(6): 408-17.
[63]
Dangre PV, Gilhotra KM, Dhole SN. Formulation and development of solid self micro-emulsifying drug delivery system (S-SMEDDS) containing chlorthalidone for improvement of dissolution. J Pharm Investig 2016; 46(7): 633-44.
[http://dx.doi.org/10.1007/s40005-016-0243-2]
[64]
Quan G, Wu Q, Zhang X, et al. Enhancing in vitro dissolution and in vivo bioavailability of fenofibrate by solid self-emulsifying matrix combined with SBA-15 mesoporous silica. Colloids Surf B Biointerfaces 2016; 141: 476-82.
[http://dx.doi.org/10.1016/j.colsurfb.2016.02.013] [PMID: 26896653]
[65]
Inugala S, Eedara BB, Sunkavali S, Dhurke R, Kandadi P, et al. Solid self-nanoemulsifying drug delivery system (S-SMEDDS) of darunavir for improved oral dissolution and oral bioavailability. Eur J Pharm Sci 2016; 74: 1-10.
[http://dx.doi.org/10.1016/j.ejps.2015.03.024] [PMID: 25845633]
[66]
Soliman KA, Ibrahim HK, Ghorab MM. Formulation of avanafil in a solid self-nanoemulsifying drug delivery system for enhanced oral delivery. Eur J Pharm Sci 2016; 93: 447-55.
[http://dx.doi.org/10.1016/j.ejps.2016.08.050] [PMID: 27590128]
[67]
Beg S, Katare OP, Saini S, Garg B, Khurana RK, Singh B. Solid self-nanoemulsifying systems of olmesartan medoximil: Formulation development, micromeretic characterization and in vivo evaluation. Powder Technol 2016; 294: 93-104.
[http://dx.doi.org/10.1016/j.powtec.2016.02.023]
[68]
Chavan RB, Modi SR, Bansal AK. Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib. Int J Pharm 2015; 495(1): 374-84.
[http://dx.doi.org/10.1016/j.ijpharm.2015.09.011] [PMID: 26364711]
[69]
Park JB, Choi BK, Kang CY. Effect of adsorbent materials on a self-emulsifying drug delivery system for a poorly soluble drug. J Pharm Investig 2015; 45: 529-39.
[http://dx.doi.org/10.1007/s40005-015-0201-4]
[70]
Cho W, Kim MS, Kim JS, et al. Optimized formulation of solid self-microemulsifying sirolimus delivery systems. Int J Nanomedicine 2013; 8: 1673-82.
[PMID: 23641156]
[71]
Čerpnjak K, Zvonar A, Vrečer F, Gašperlin M. Development of a solid self-microemulsifying drug delivery system (SMEDDS) for solubility enhancement of naproxen. Drug Dev Ind Pharm 2015; 41(9): 1548-57.
[http://dx.doi.org/10.3109/03639045.2014.971031] [PMID: 25308746]
[72]
Deshmukh A, Kulkarni S. Solid self-microemulsifying drug delivery system of ritonavir. Drug Dev Ind Pharm 2014; 40(4): 477-87.
[http://dx.doi.org/10.3109/03639045.2013.768632] [PMID: 23465049]
[73]
Khutle NM, Vijaya C. Formulation studies on novel self-solidifying self-nanoemulsifying drug delivery systems of nebivolol hydrochloride. Pharm Nanotechnol 2014; 2: 87-100.
[http://dx.doi.org/10.2174/2211738502666141014212524]
[74]
Kallakunta VR, Eedera BB, Jukanti R, Ajmeera RK, Bhandari S. A Gelicure 44/14 and Labrasol based solid self-emulsifying drug delivery system: formulation and evaluation. J Pharm Investig 2013; 43: 185-96.
[http://dx.doi.org/10.1007/s40005-013-0060-9]
[75]
Milović M, Djuriš J, Djekić L, Vasiljević D, Ibrić S. Characterization and evaluation of solid self-microemulsifying drug delivery systems with porous carriers as systems for improved carbamazepine release. Int J Pharm 2012; 436(1-2): 58-65.
[http://dx.doi.org/10.1016/j.ijpharm.2012.06.032] [PMID: 22721847]
[76]
Zhang L, Zhang L, Zhang M, et al. Self-emulsifying drug delivery system and the applications in herbal drugs. Drug Deliv 2015; 22(4): 475-86.
[http://dx.doi.org/10.3109/10717544.2013.861659] [PMID: 24321014]
[77]
Chouhan N, Mittal V, Kaushik D, Khatkar A, Raina M. Self emulsifying drug delivery system (SEDDS) for phytoconstituents: A review. Curr Drug Deliv 2015; 12(2): 244-53.
[http://dx.doi.org/10.2174/1567201811666141021142606] [PMID: 25335929]
[78]
Huang J, Gong W, Chen Z, et al. Emodin self-emulsifying platform ameliorates the expression of FN, ICAM-1 and TGF-β1 in AGEs-induced glomerular mesangial cells by promoting absorption. Eur J Pharm Sci 2017; 99: 128-36.
[http://dx.doi.org/10.1016/j.ejps.2016.12.012] [PMID: 27988328]
[79]
Gu Z, Shi X, Siaw E, Zhu Y, Li H, et al. Self-microemulsifying sustained-release pellet of Ginkgo biloba extract: Preparation, in vitro drug release and pharmacokinetics study in beagle dogs. J Drug Deliv Sci Technol 2017; 37: 184-93.
[http://dx.doi.org/10.1016/j.jddst.2017.01.002]
[80]
Sangsen Y, Wiwattanawongsa K, Likhitwitayawuid K, Sritularak B, Graidist P, Wiwattanapatapee R. Influence of surfactants in self-microemulsifying formulations on enhancing oral bioavailability of oxyresveratrol: Studies in Caco-2 cells and in vivo. Int J Pharm 2016; 498(1-2): 294-303.
[http://dx.doi.org/10.1016/j.ijpharm.2015.12.002] [PMID: 26680318]
[81]
Mamadou G, Charrueau C, Dairou J, Limas Nzouzi N, Eto B, Ponchel G. Increased intestinal permeation and modulation of presystemic metabolism of resveratrol formulated into self-emulsifying drug delivery systems. Int J Pharm 2017; 521(1-2): 150-5.
[http://dx.doi.org/10.1016/j.ijpharm.2017.02.036] [PMID: 28216465]
[82]
Ke Z, Hou X, Jia XB. Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D. Drug Des Devel Ther 2016; 10: 2049-60.
[http://dx.doi.org/10.2147/DDDT.S106356] [PMID: 27418807]
[83]
Bi X, Liu X, Di L, Zu Q. Improved oral bioavailability using a solid self-microemulsifying drug delivery system containing a multicomponent mixture extracted from salvia miltiorrhiza. Molecules 2016; 21(4): 456-67.
[http://dx.doi.org/10.3390/molecules21040456] [PMID: 27070565]
[84]
Shakeel F, Raish M, Anwer MK, Shdefat R. Self-nanoemulsifying drug delivery system of sinapic acid: In vitro and in vivo evaluation. J Mol Lipids 2016; 224: 351-8.
[http://dx.doi.org/10.1016/j.molliq.2016.10.017]
[85]
Chow PY, Gue SZ, Leow SK, Goh BL. Solid self-microemulsifying system (S-SMEDDS) for enhanced bioavailability and pigmentation of highly lipophilic bioactive carotenoid. Powder Technol 2016; 274: 199-204.
[http://dx.doi.org/10.1016/j.powtec.2015.01.020]
[86]
Yang XU, Wang Q, Feng Y, Firempong CK, Zhu Y, et al. Enhanced oral bioavailability of [6]-Gingerol-SMEDDS: Preparation, in vitro and in vivo evaluation. J Funct Foods 2016; 27: 703-10.
[http://dx.doi.org/10.1016/j.jff.2016.10.007]
[87]
Chen ZQ, Liu Y, Zhao JH, Wang L, Feng NP. Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system. Int J Nanomedicine 2012; 7: 1115-25.
[PMID: 22403491]
[88]
Shehata EM, Elnaggar YS, Galal S, Abdallah OY. Self-emulsifying phospholipid pre-concentrates (SEPPs) for improved oral delivery of the anti-cancer genistein: Development, appraisal and ex-vivo intestinal permeation. Int J Pharm 2016; 511(2): 745-56.
[http://dx.doi.org/10.1016/j.ijpharm.2016.07.078] [PMID: 27492016]
[89]
Li Q, Zhai W, Jiang Q, et al. Curcumin-piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy. Int J Pharm 2015; 490(1-2): 22-31.
[http://dx.doi.org/10.1016/j.ijpharm.2015.05.008] [PMID: 25957703]
[90]
Zhu JX, Tang D, Feng L, et al. Development of self-microemulsifying drug delivery system for oral bioavailability enhancement of berberine hydrochloride. Drug Dev Ind Pharm 2013; 39(3): 499-506.
[http://dx.doi.org/10.3109/03639045.2012.683875] [PMID: 22563917]
[91]
Cui J, Yu B, Zhao Y, et al. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm 2009; 371(1-2): 148-55.
[http://dx.doi.org/10.1016/j.ijpharm.2008.12.009] [PMID: 19124065]
[92]
Duc Hanh N, Mitrevej A, Sathirakul K, Peungvicha P, Sinchaipanid N. Development of phyllanthin-loaded self-microemulsifying drug delivery system for oral bioavailability enhancement. Drug Dev Ind Pharm 2015; 41(2): 207-17.
[http://dx.doi.org/10.3109/03639045.2013.858732] [PMID: 24237327]
[93]
Bolko K, Zvonar A, Gašperlin M. Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility. Drug Dev Ind Pharm 2014; 40(1): 102-9.
[http://dx.doi.org/10.3109/03639045.2012.749888] [PMID: 23301796]
[94]
Liu W, Tian R, Hu W, et al. Preparation and evaluation of self-microemulsifying drug delivery system of baicalein. Fitoterapia 2012; 83(8): 1532-9.
[http://dx.doi.org/10.1016/j.fitote.2012.08.021] [PMID: 22982454]
[95]
Zupančič O, Rohrer J, Thanh Lam H, Grießinger JA, Bernkop-Schnürch A. Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery. Drug Dev Ind Pharm 2017; 43(10): 1694-702.
[http://dx.doi.org/10.1080/03639045.2017.1338722] [PMID: 28589736]
[96]
Mahmood A, Prüfert F, Efiana NA, et al. Cell-penetrating self-nanoemulsifying drug delivery systems (SNEDDS) for oral gene delivery. Expert Opin Drug Deliv 2016; 13(11): 1503-12.
[http://dx.doi.org/10.1080/17425247.2016.1213236] [PMID: 27458781]
[97]
Hauptstein S, Prüfert F, Bernkop-Schnürch A. Self-nanoemulsifying drug delivery systems as novel approach for pDNA drug delivery. Int J Pharm 2015; 487(1-2): 25-31.
[http://dx.doi.org/10.1016/j.ijpharm.2015.03.064] [PMID: 25839413]
[98]
Agarwal AG, Kumar A, Gide PS. Formulation development and in vivo hepatoprotective activity of self nanoemulsifying drug delivery system of antioxidant coenzyme Q10. Arch Pharma Res 2015.
[99]
Hintzen F, Perera G, Hauptstein S, Müller C, Laffleur F, Bernkop-Schnürch A. In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin. Int J Pharm 2014; 472(1-2): 20-6.
[http://dx.doi.org/10.1016/j.ijpharm.2014.05.047] [PMID: 24879935]
[100]
Zhang G, Wang T, Gao L, Quan D. Oral delivery of oil-based formulation for a novel synthetic cationic peptide of GnRH (gonadotropin-releasing hormone) antagonist for prostate cancer treatment. Int J Pharm 2013; 450(1-2): 138-44.
[http://dx.doi.org/10.1016/j.ijpharm.2013.04.047] [PMID: 23623791]
[101]
Gürsoy RN, Çevik Ö. Design, characterization and in vitro evaluation of SMEDDS containing an anticancer peptide, linear LyP-1. Pharm Dev Technol 2014; 19(4): 486-90.
[http://dx.doi.org/10.3109/10837450.2013.795170] [PMID: 23678858]
[102]
Li P, Tan A, Prestidge CA, Nielsen HM, Müllertz A. Self-nanoemulsifying drug delivery systems for oral insulin delivery: In vitro and in vivo evaluations of enteric coating and drug loading. Int J Pharm 2014; 477(1-2): 390-8.
[http://dx.doi.org/10.1016/j.ijpharm.2014.10.039] [PMID: 25455781]
[103]
Xu S, Dai WG. Drug precipitation inhibitors in supersaturable formulations. Int J Pharm 2013; 453(1): 36-43.
[http://dx.doi.org/10.1016/j.ijpharm.2013.05.013] [PMID: 23680727]
[104]
Stillhart C, Kuentz M. Trends in the assessment of super saturation and precipitation in vitro using lipid based delivery systems. J Pharm Sci 2016; 105(9): 2468-76.
[http://dx.doi.org/10.1016/j.xphs.2016.01.010] [PMID: 26935881]
[105]
Anby MU, Williams HD, McIntosh M, et al. Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems. Mol Pharm 2012; 9(7): 2063-79.
[http://dx.doi.org/10.1021/mp300164u] [PMID: 22656917]
[106]
Yeom DW, Chae BR, Son HY, et al. Enhanced oral bioavailability of valsartan using a polymer-based supersaturable self-microemulsifying drug delivery system. Int J Nanomedicine 2017; 12: 3533-45.
[http://dx.doi.org/10.2147/IJN.S136599] [PMID: 28507434]
[107]
Quan G, Niu B, Singh V, et al. Supersaturable solid self-microemulsifying drug delivery system: Precipitation inhibition and bioavailability enhancement. Int J Nanomedicine 2017; 12: 8801-11.
[http://dx.doi.org/10.2147/IJN.S149717] [PMID: 29263669]
[108]
Lee DR, Ho MJ, Jung HJ, et al. Enhanced dissolution and oral absorption of tacrolimus by supersaturable self-emulsifying drug delivery system. Int J Nanomedicine 2016; 11: 1109-17.
[PMID: 27051286]
[109]
Kim MS, Ha ES, Choo GS, Baek IH. Preparation and in vivo evaluation of a Dutaseride loaded self-microemulsifying drug delivery system. Int J Mol Sci 2015; 16: 10821-33.
[http://dx.doi.org/10.3390/ijms160510821] [PMID: 25984604]
[110]
Dash RN, Mohammed H, Humaira T, Reddy AV. Solid supersaturable self-nanoemulsifying drug delivery system for improved dissolution, absorption and pharmacodynamic effects of glipizide. J Drug Deliv Sci Technol 2015; 28: 28-36.
[http://dx.doi.org/10.1016/j.jddst.2015.05.004]
[111]
Wei Y, Ye X, Shang X, Peng X, Bao Q, Liu M, et al. Enhanced oral bioavailability of silybin by a supersaturable self-emulsifying drug delivery system (S-SEDDS). Colloids Surf A Physicochem Eng Asp 2013; 396: 22-8.
[http://dx.doi.org/10.1016/j.colsurfa.2011.12.025]
[112]
Thomas N, Holm R, Müllertz A, Rades T. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS). J Control Release 2012; 160(1): 25-32.
[http://dx.doi.org/10.1016/j.jconrel.2012.02.027] [PMID: 22405903]
[113]
Mingfeng Q, Jing S, Ran Z, Xiumei Z, Pengcheng G. Berberine species contained gelatin encapsulated nanoparticles erythrocyte membrane preparation and their use Chinese Patent (CN108113977A) 2018.
[114]
Linfang L. Salfinamide self-microemulsion preparation and preparation method there of Chinese Patent (CN 106619513 A) 2017
[115]
Zhi Z, Cui W, Qi F, Jun R, Wei Z, Jing W. SMEDDS macroantholides saponin and its applications B. Chinese Patent (CN 108078922 A) 2017
[116]
Linfang L. Hydrochloride Lurasidone one kind and preparation method SMEDDS Chinese Patent (CN 108042489 A) 2017
[117]
Linfang L. Species must dronedarone hydrochloride its preparation method SMEDDSChinese Patent (CN 108042489 A), 2017
[118]
Karasulu HY, Apaydin S, Gondogdu E, et al. Turgay T. Selfmicro/ nanoemulsifying drug carrying system for oral use of rosuvastatin Worldwide Application (WO 2015142307 A1), 2015
[119]
Legen I, Kerc Z, Jurkovic P. Self-microemulsifying drug delivery systems. US Patent (US 8592490 E2) 2015.
[120]
Yang YT, Wang JJ, Hsu PJ, Chang LC, Hao WH, Hsu CH. Oral administration of unstable or poorly-absorbed drugs Worldwide Application (WO 2016071756 A1) 2016
[121]
Malhotra G, Purandare SM. Pharmaceutical compositions comprising efavirenz Worldwide Application (WO 2015059466 A1) 2014
[122]
Xiaoying L, Changshun L, Zheng Y, Yingfeng Z. Berberine hydrochloride self-microemulsion preparation having good oral bioavailability and preparation method thereof Chinese Patent (CN 104825389 A), 2015.
[123]
Dakun H, Huailong G. Diclazuril SMEDDS and preparation method Chinese Patent (CN104055733 B) 2014.
[124]
Rongping Y, Yunhong W, Yao J, et al. Indirubin One kind SMEDDS its preparation method Chinese Patent (CN104055733 B), 2014
[125]
Legen I, Peternel L, Novak SM, Homar M, Rozman PT, Klancer U. Self-microemulsifying drug delivery system of abiraterone or abiraterone acetate Worldwide Application (WO 2014009434 A1), 2013.
[126]
Gursoy RN, Cevik O. Lipid-based nanocarrier systems for using cancer treatment Worldwide Application (WO 2013100869 A2), 2013.
[127]
Lin Z. Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10. US Patent (US8252326 B2), 2012
[128]
Dongkai W, Xiaojun Z. Tinidazole/miconazole nitrate/neomycin self-microemulsion soft capsules for vagina and preparation method thereof. Chinese Patent (CN 101703517 B), 2013.
[129]
Takasagi NL, Guardian LW. Preparation method of nimoldipine self-microemulsion osmotic pump sustained release capsule Chinese Patent (CN 103054834 B), 2013.
[130]
Berge G, Olesen PH, Hustvedt SO, Mullertz A, Klaveness JE. Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture Worldwide Application (WO 2013072767 A1), 2012.
[131]
Daping Z, Weigen L, Quanhai L. One kind of Asiatic acid SMEDDS system and preparation method Chinese Patent CN102784096B, 2012.
[132]
Jun H, Mengliang W, Wenxue D. Alley. Ginsenoside Rh 1 selfmicroemulsion composition, and preparation method and application thereof. Chinese Patent (CN 103381142 A), 2012
[133]
Rongfeng H, Zhongwen B. Takamatsu. Self-microemulsion based on spherical crystallization technique and preparation method thereof. Chinese Patent (CN 103315960 A), 2012.
[134]
Kim AE, Dintaman JM, Waddell DS, Silverman JA. Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein. J Pharmacol Exp Ther 1998; 286(3): 1439-45.
[PMID: 9732409]
[135]
Schmitt C, Kaeser B, Riek M, Bech N, Kreuzer C. Effect of saquinavir/ritonavir on P-glycoprotein activity in healthy volunteers using digoxin as a probe. Int J Clin Pharmacol Ther 2010; 48(3): 192-9.
[http://dx.doi.org/10.5414/CPP48192] [PMID: 20197013]
[136]
Savla R, Browne J, Plassat V, Wasan KM, Wasan EK. Review and analysis of FDA approved drugs using lipid-based formulations. Drug Dev Ind Pharm 2017; 43(11): 1743-58.
[http://dx.doi.org/10.1080/03639045.2017.1342654] [PMID: 28673096]
[137]
Feeney OM, Crum MF, McEvoy CL, et al. 50 years of oral lipid-based formulations: Provenance, progress and future perspectives. Adv Drug Deliv Rev 2016; 101: 167-94.
[http://dx.doi.org/10.1016/j.addr.2016.04.007] [PMID: 27089810]
[138]
Strickley RG. Currently marketed oral lipid-based dosage forms: drug products and excipients. In: Oral Lipid Based Formulations. Hauss D, editor. Oral Lipid Based Formulations. 1st ed. New York: Informa Healthcare 2007; pp. 38-55.
[139]
Mendez R, Abboud H, Burdick J, et al. Reduced intrapatient variability of cyclosporine pharmacokinetics in renal transplant recipients switched from oral Sandimmune to Neoral. Clin Ther 1999; 21(1): 160-71.
[http://dx.doi.org/10.1016/S0149-2918(00)88276-4] [PMID: 10090433]
[140]
Katneni K, Charman SA, Porter CJ. Impact of cremophor-EL and polysorbate-80 on digoxin permeability across rat jejunum: delineation of thermodynamic and transporter related events using the reciprocal permeability approach. J Pharm Sci 2007; 96(2): 280-93.
[http://dx.doi.org/10.1002/jps.20779] [PMID: 17051595]
[141]
Wacher VJ, Silverman JA, Zhang Y, Benet LZ. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. J Pharm Sci 1998; 87(11): 1322-30.
[http://dx.doi.org/10.1021/js980082d] [PMID: 9811484]
[142]
Chen XQ, Gudmundsson OS, Hageman MJ. Application of lipid-based formulations in drug discovery. J Med Chem 2012; 55(18): 7945-56.
[http://dx.doi.org/10.1021/jm3006433] [PMID: 22779739]

Rights & Permissions Print Cite
Article Metrics
52
5
1
© 2024 Bentham Science Publishers | Privacy Policy